Full-Time

Thought Leader Liaison

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$139.8k - $205.6kAnnually

Senior, Expert

No H1B Sponsorship

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Corcept Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Advanced degree in sciences
  • Experience working with specialty pharmaceutical products and therapeutic areas
  • Previous experience in Thought Leader Development or related roles
  • Proven track record of successful thought leader engagement and advocacy initiatives
  • Strong personal leadership skills to drive performance and support corporate objectives
  • Ability to work collaboratively and effectively with others
  • Ability to work under pressure and meet deadlines
  • Strong analytical and communication skills
  • Well organized and meticulous
  • Creativity and resilience in problem solving
  • Relentless hands-on drive to implement and accomplish performance goals
Responsibilities
  • Identify, establish, and nurture relationships with thought leaders, healthcare professionals, and key opinion leaders in relevant therapeutic areas
  • Engage in meaningful and strategic discussions to gather insights, share clinical information, and build advocacy for our pharmaceutical offerings
  • Collaborate with cross-functional teams including Marketing, Medical Affairs, Sales, and Clinical Development to develop and execute thought leader engagement plans that align with various business objectives
  • Provide thought leaders with accurate and up-to-date scientific and clinical information
  • Act as a scientific resource, addressing inquiries, and facilitating discussions to enhance thought leader understanding and endorsement of our products
  • Identify potential thought leaders who can serve as speakers for educational programs, advisory boards, and other promotional activities
  • Collaborate with Medical Affairs and Marketing teams to develop speaker training programs and materials
  • Identify potential thought leaders best suited to contribute valuable and necessary feedback to various key commercial initiatives via participation in advisory meetings and steering committees
  • Gather and communicate valuable market insights, competitive intelligence, and emerging trends to internal stakeholders
  • Leverage this information to inform product positioning, messaging, and strategic decision-making
  • Develop and execute thought leadership initiatives such as webinars, symposia, and advisory board meetings
  • Contribute to local/regional/national conference planning efforts to foster engagement, knowledge exchange, and scientific collaboration among thought leaders and the broader medical community
  • Ensure all interactions and activities with thought leaders adhere to company policies, industry regulations, and compliance guidelines
Desired Qualifications
  • Bachelor's degree in a relevant field is required. Advanced degree (Masters, PharmD, PhD) is a plus
  • Minimum of 8 years of experience in the pharmaceutical or biotech industry, with a proven track record of success and progression
  • Demonstrated expertise in marketing strategies within the pharmaceutical industry. Launch experience is a plus
  • Strong network and established relationships with key opinion leaders and thought leaders in relevant therapeutic areas
  • Exceptional interpersonal and communication skills, with the ability to engage and influence thought leaders effectively
  • Thorough understanding of medical and scientific concepts, and the ability to translate complex information into clear and concise messaging
  • Proven ability to collaborate cross-functionally and lead projects within a matrixed organization
  • Strong organizational skills and attention to detail
  • Ability to adapt to a fast-paced, dynamic environment and manage multiple priorities
  • In-depth knowledge of industry regulations and compliance guidelines related to interactions with healthcare professionals
  • Ability to travel as needed to engage with thought leaders and attend conferences, meetings, and events. Travel requirements will vary by territory, but could be up to 60% and will involve overnight travel

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing stress, metabolism, and immune functions. Their main product, Korlym, is the first FDA-approved treatment for Cushing's syndrome, a condition caused by excessive cortisol. The company has discovered over 1,000 selective cortisol modulators and aims to expand its offerings with new treatments in development. Unlike many competitors, Corcept emphasizes both research and patient education, providing resources to healthcare professionals and patients to improve understanding and care for cortisol-related disorders. The goal of Corcept is to lead in cortisol modulation therapies and enhance the quality of life for patients suffering from conditions related to cortisol imbalance.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
  • Advancements in drug delivery systems could enhance Corcept's product efficacy.
  • The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
  • Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
  • Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours